Across Canada, healthcare providers are thoroughly adjusting their approaches to BZD prescribing following the publication of updated guidelines. These recommendations aim to lower the potential harms associated with long-term use and addiction, emphasizing the necessity of thorough patient evaluations and considering different therapy choices. The